Altimmune Inc. (ALT) attracts a new wave of investors despite economic turmoil

The closing price of Altimmune Inc. (NASDAQ: ALT) was $9.31 for the day, up 6.52% from the previous closing price of $8.74. In other words, the price has increased by $+0.57 from its previous closing price. On the day, 801386 shares were traded. ALT stock price reached its highest trading level at $9.33 during the session, while it also had its lowest trading level at $8.29.

Do You Own These 7 Inflation-Survival Stocks?

Inflation is still near 40-year highs and rising prices are putting a big dent in our wallets. Unless you find out how to protect your portfolio and outpace inflation, you'll keep being at the mercy of economic factors out of your control. Especially since the price of electricity, food, and shelter are creeping up higher than ever. In this special report, I detail 7 stocks to help you survive and thrive in today's market. They're backed by solid companies, positioned to profit during tough economic times, and offer out-sized dividends to help you outpace inflation.

Click here to get your free copy of the report



Our analysis of ALT’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 13.40 and its Current Ratio is at 13.40. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.

Upgrades & Downgrades

On June 02, 2021, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $35.

On February 11, 2021, Guggenheim started tracking the stock assigning a Buy rating and target price of $36.Guggenheim initiated its Buy rating on February 11, 2021, with a $36 target price.

Insider Transactions:

Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Aug 31 when Garg Vipin K sold 20,000 shares for $20.02 per share. The transaction valued at 400,322 led to the insider holds 236,797 shares of the business.

Garg Vipin K sold 15,000 shares of ALT for $225,890 on Aug 12. The President and CEO now owns 259,804 shares after completing the transaction at $15.06 per share. On Jul 05, another insider, Roberts M Scot, who serves as the Chief Scientific Officer of the company, sold 10,182 shares for $12.00 each. As a result, the insider received 122,184 and left with 8,305 shares of the company.

Valuation Measures:

For the stock, the TTM Price-to-Sale (P/S) ratio is 137.90 while its Price-to-Book (P/B) ratio in mrq is 2.24.

Stock Price History:

Over the past 52 weeks, ALT has reached a high of $23.49, while it has fallen to a 52-week low of $3.83. The 50-Day Moving Average of the stock is 11.68, while the 200-Day Moving Average is calculated to be 9.96.

Shares Statistics:

ALT traded an average of 2.33M shares per day over the past three months and 1.36M shares per day over the past ten days. A total of 49.29M shares are outstanding, with a floating share count of 48.81M. Insiders hold about 0.60% of the company’s shares, while institutions hold 94.60% stake in the company. Shares short for ALT as of Oct 13, 2022 were 7.05M with a Short Ratio of 7.16M, compared to 6.76M on Sep 14, 2022. Therefore, it implies a Short% of Shares Outstanding of 14.38% and a Short% of Float of 14.50%.

Earnings Estimates

The firm’s stock currently is rated by 6 analysts. On average, analysts expect EPS of -$0.5 for the current quarter, with a high estimate of -$0.44 and a low estimate of -$0.57, while EPS last year was -$0.81. The consensus estimate for the next quarter is -$0.48, with high estimates of -$0.32 and low estimates of -$0.57.

Analysts are recommending an EPS of between -$1.75 and -$2.08 for the fiscal current year, implying an average EPS of -$1.88. EPS for the following year is -$2.07, with 7 analysts recommending between -$1.72 and -$2.5.